Novalis Biotech is an early-stage venture capital investor in the life sciences. With an interest in innovative concepts in healthcare, Novalis aims to support their development at the earliest stages.

Novalis’ investment focus is “enabling technologies” in the life sciences, i.e. those that enable fast and comprehensive leaps in performance and capability. Focus areas include innovative research and manufacturing tools, bioinformatics, genomics, diagnostics and digital health.

Early-stage start-ups are given the most attention, from (pre-)seed stage to series A, and Novalis supports their evolution by providing funding, sharing professional and academic connections, and helping to shape a business strategy to create value for all stakeholders.

Qbic is an inter-university venture capital fund focusing on the transformation of technological breakthroughs into sustainable businesses. The fund focuses on early-stage venture capital funding, supporting spin-offs and start-ups that valorize research from their knowledge partners.

Qbic typically participates in the first external investment round of a company, and continues to support and fund these companies throughout their growth. With a passion for innovating technology and a clear understanding of business dynamics, Qbic has worked with 37 companies, put over €300M of total funding into young companies, and created over 950 jobs.